242 related articles for article (PubMed ID: 24607340)
21. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.
Hoekstra M; Li Z; Kruijt JK; Van Eck M; Van Berkel TJ; Kuiper J
J Hepatol; 2010 Feb; 52(2):244-51. PubMed ID: 20015565
[TBL] [Abstract][Full Text] [Related]
22. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
23. Steatosis in the liver.
Wang DQ; Portincasa P; Neuschwander-Tetri BA
Compr Physiol; 2013 Oct; 3(4):1493-532. PubMed ID: 24265237
[TBL] [Abstract][Full Text] [Related]
24. De novo lipogenesis in health and disease.
Ameer F; Scandiuzzi L; Hasnain S; Kalbacher H; Zaidi N
Metabolism; 2014 Jul; 63(7):895-902. PubMed ID: 24814684
[TBL] [Abstract][Full Text] [Related]
25. Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes.
Gnocchi D; Massimi M; Alisi A; Incerpi S; Bruscalupi G
Horm Metab Res; 2014 May; 46(5):333-40. PubMed ID: 24816759
[TBL] [Abstract][Full Text] [Related]
26. Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation.
Grattagliano I; de Bari O; Bernardo TC; Oliveira PJ; Wang DQ; Portincasa P
Clin Biochem; 2012 Jun; 45(9):610-8. PubMed ID: 22484459
[TBL] [Abstract][Full Text] [Related]
27. Direct effects of iodothyronines on excess fat storage in rat hepatocytes.
Grasselli E; Voci A; Canesi L; De Matteis R; Goglia F; Cioffi F; Fugassa E; Gallo G; Vergani L
J Hepatol; 2011 Jun; 54(6):1230-6. PubMed ID: 21145833
[TBL] [Abstract][Full Text] [Related]
28. Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy.
Kopec KL; Burns D
Nutr Clin Pract; 2011 Oct; 26(5):565-76. PubMed ID: 21947639
[TBL] [Abstract][Full Text] [Related]
29. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
30. CIDE proteins and lipid metabolism.
Xu L; Zhou L; Li P
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1094-8. PubMed ID: 22517368
[TBL] [Abstract][Full Text] [Related]
31. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
32. Cellular glutathione in fatty liver in vitro models.
Garcia MC; Amankwa-Sakyi M; Flynn TJ
Toxicol In Vitro; 2011 Oct; 25(7):1501-6. PubMed ID: 21620948
[TBL] [Abstract][Full Text] [Related]
33. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523
[TBL] [Abstract][Full Text] [Related]
34. Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase.
Fujimoto Y; Onoduka J; Homma KJ; Yamaguchi S; Mori M; Higashi Y; Makita M; Kinoshita T; Noda J; Itabe H; Takanoa T
Biol Pharm Bull; 2006 Nov; 29(11):2174-80. PubMed ID: 17077510
[TBL] [Abstract][Full Text] [Related]
35. Perspectives on Mitochondria-ER and Mitochondria-Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism.
Ma X; Qian H; Chen A; Ni HM; Ding WX
Cells; 2021 Sep; 10(9):. PubMed ID: 34571924
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of disease progression in nonalcoholic fatty liver disease.
Jou J; Choi SS; Diehl AM
Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
[TBL] [Abstract][Full Text] [Related]
37. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
38. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
39. Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease.
Natarajan SK; Rasineni K; Ganesan M; Feng D; McVicker BL; McNiven MA; Osna NA; Mott JL; Casey CA; Kharbanda KK
Curr Mol Pharmacol; 2017; 10(3):237-248. PubMed ID: 26278390
[TBL] [Abstract][Full Text] [Related]
40. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
